Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Pulse Biosciences CS (NQ: PLSE ) 17.26 +0.37 (+2.19%) Streaming Delayed Price Updated: 10:50 AM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 26,112 Open 17.18 Bid (Size) 17.06 (1) Ask (Size) 17.26 (3) Prev. Close 16.89 Today's Range 16.68 - 17.26 52wk Range 3.780 - 22.69 Shares Outstanding 54,902,942 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News PLSE Stock Earnings: Pulse Biosciences Reported Results for Q2 2024 August 22, 2024 Pulse Biosciences just reported results for the second quarter of 2024. Via InvestorPlace Loar Holdings Posts Upbeat Results, Joins Nvidia, Clean Energy Fuels, Penumbra And Other Big Stocks Moving Higher On Tuesday August 13, 2024 Via Benzinga Performance YTD +56.62% +56.62% 1 Month -5.89% -5.89% 3 Month +56.77% +56.77% 6 Month +98.16% +98.16% 1 Year +316.91% +316.91% More News Read More Pulse Biosciences Reports Business Updates and Preliminary Second Quarter 2024 Financial Results August 12, 2024 From Pulse Biosciences, Inc. Via Business Wire Pulse Biosciences, Inc. Appoints Paul LaViolette to Its Board of Directors August 12, 2024 From Pulse Biosciences, Inc. Via Business Wire PLSE Stock Earnings: Pulse Biosciences Reported Results for Q1 2024 May 07, 2024 Via InvestorPlace Pulse Biosciences, Inc. Announces Successful Treatment of Patients in First-in-Human Study with its Nano-PFA Cardiac Surgery System August 08, 2024 From Pulse Biosciences, Inc. Via Business Wire Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences August 01, 2024 From Pulse Biosciences, Inc. Via Business Wire Pulse Biosciences Schedules Second Quarter 2024 Financial Results Conference Call for August 12, 2024 July 29, 2024 From Pulse Biosciences, Inc. Via Business Wire Russell 2000 Index Notches Strongest Week Of Year, Hits 31-Month Highs: Outlook Is 'Clouded By Fed's Concerns Over Labor Market,' Analyst Warns July 12, 2024 Via Benzinga Topics Economy Exposures Interest Rates Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session July 08, 2024 Via Benzinga S&P 500, Nasdaq Extend Record Highs; Dow Up Triple Digits July 08, 2024 Via Talk Markets Topics Economy Stocks Exposures Interest Rates US Equities Corning Increases Sales Forecast, Joins Morphic Holding, Lucid Group And Other Big Stocks Moving Higher On Monday July 08, 2024 Via Benzinga Pulse Biosciences, Inc. Announces Receipt of FDA Breakthrough Device Designation for CellFX® nsPFA Cardiac Surgery System for the Treatment of Atrial Fibrillation July 08, 2024 From Pulse Biosciences, Inc. Via Business Wire Pulse Biosciences, Inc. Announces the Closing of its Rights Offering July 03, 2024 From Pulse Biosciences, Inc. Via Business Wire Pulse Biosciences, Inc. Announces Preliminary Results for its Rights Offering June 28, 2024 From Pulse Biosciences, Inc. Via Business Wire 12 Health Care Stocks Moving In Friday's Intraday Session May 31, 2024 Via Benzinga Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session May 31, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session May 31, 2024 Via Benzinga Pulse Biosciences Announces Updated Timing of Rights Offering for Up to $60,000,000 May 20, 2024 From Pulse Biosciences, Inc. Via Business Wire Pulse Biosciences’ CellFX Nanosecond Pulsed Field Ablation (nsPFA™) Technology to be Featured in Several Presentations at The Heart Rhythm Society 2024 Annual Meeting May 16, 2024 From Pulse Biosciences, Inc. Via Business Wire Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session May 15, 2024 Via Benzinga Pulse Biosciences Enhances Executive Leadership Team May 14, 2024 From Pulse Biosciences, Inc. Via Business Wire Pulse Biosciences Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode System May 09, 2024 From Pulse Biosciences, Inc. Via Business Wire Pulse Biosciences Reports Business Updates and First Quarter 2024 Financial Results May 07, 2024 From Pulse Biosciences, Inc. Via Business Wire Pulse Biosciences Announces Timing of Rights Offering for Up to $60,000,000 May 02, 2024 From Pulse Biosciences, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
